EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation

Philip M Langer, Alison J Clare, Xudong Peng, Katherine L Costello, Suci Cendanawati, Leslie L Wilson, Amy Ward, Oliver H Bell, Colin J Chu, Ying Kai Chan, Andrew D Dick, Kathryn L Pepple und 1 weitere

Molecular Therapy · 2026

DOI: 10.1016/j.ymthe.2026.02.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Philip M Langer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK; Department of Ophthalmology, School of Medicine, …. Hauptthemen laut MEDLINE: Microglia, Dependovirus, Uveitis, Receptors, Lysosphingolipid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NEI NIH HHS, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation elicited by rAAV vectors continues to present a critical challenge for the long-term efficacy and safety of gene therapy in the eye. Preclinical models of gene therapy-associated uveitis (GTAU) show that despite the resolution of early acute inflammatory response, persistent subclinical inflammation remains. Here, we employ the GTAU model in Cx3cr1CreER:R26-tdTomato+/- mice to reveal that intravitreal rAAV2 administration elicits sustained microglial dysregulation and retention of CD3+ T cells extending to 50 days post-injection. Deploying pharmacologic and genetic approaches, we define the absolute requirement for microglia and T cells to mediate rAAV2-induced inflammation. Targeted depletion confirmed that microglia-independent mechanisms initiate GTAU, while elimination of lymphocytes prevented both inflammation and microglial activation. Systematic evaluation of therapeutic strategies reveals identified inhibition of T cell recruitment via sphingosine-1-phosphate receptor modulation, but not B cell depletion, as an effective steroid-sparing strategy to prevent both acute and long-term subclinical inflammation. Collectively, our findings challenge the paradigm of microglia-driven ocular inflammation and support the utility of targeted T cell immunomodulation strategies to control GTAU and maintain long-term ocular homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaDependovirusUveitisReceptors, LysosphingolipidInflammationGenetic VectorsAnimalsMiceT-LymphocytesDisease Models, AnimalGenetic TherapyGene Therapy Agents

Stichwörter der Autor:innen

AAVGTAUadeno-associated viruseyegene therapyinflammationmicrogliaocularretinauveitisviral vector

Substanzen

Receptors, Lysosphingolipid

Autor:innen und Institutionen

  • Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK; Department of Ophthalmology, School of Medicine, University of Washington, Seattle, WA 98104, USA.
  • Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK; National Institute of Health Research (NIHR) Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundat…
  • Department of Ophthalmology, School of Medicine, University of Washington, Seattle, WA 98104, USA.
  • School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
  • Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK.
  • Academic Unit of Ophthalmology, Bristol Medical School, University of Bristol, Bristol BS8 1TD, UK; Institute of Ophthalmology, University College London, London EC1V 9EL, UK; National Institute of Health Research (NIHR…

Förderung

  • NIDDK NIH HHS
  • NEI NIH HHS
  • Research to Prevent Blindness
  • Sight Research UK
  • Wellcome Trust
  • UK Research and Innovation Medical Research Council
  • National Eye Institute
  • National Institute for Health and Care Research

Zitieren

APA

Langer, P. M., Clare, A. J., Peng, X., Costello, K. L., Cendanawati, S., Wilson, L. L., Ward, A., Bell, O. H., Chu, C. J., Chan, Y. K., Dick, A. D., Pepple, K. L., & Copland, D. A. (2026). Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2026.02.018

Vancouver

Langer PM, Clare AJ, Peng X, Costello KL, Cendanawati S, Wilson LL, et al. Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.02.018

BibTeX
@article{Langer2026,
  author = {Langer, Philip M and Clare, Alison J and Peng, Xudong and Costello, Katherine L and Cendanawati, Suci and Wilson, Leslie L and Ward, Amy and Bell, Oliver H and Chu, Colin J and Chan, Ying Kai and Dick, Andrew D and Pepple, Kathryn L and Copland, David A},
  title = {Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation},
  journal = {Molecular Therapy},
  year = {2026},
  doi = {10.1016/j.ymthe.2026.02.018}
}
Kostenlos starten →